Stay updated on Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial

Sign up to get notified when there's something new on the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies the site as revision v3.8.1 instead of v3.8.0; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-11-18T01:35:24.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The clinical-trial record for the completed Phase 1 ABBV-951 study is now displayed, with details about its Parkinson’s disease research, participant criteria, study locations, treatment arms, and measured outcomes.
    Difference
    52%
    Check dated 2026-11-10T22:43:56.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.8.0 instead of v3.7.2. The page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T22:51:39.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    A banner was added announcing NIH’s transition to using “Super Intelligence” instead of “Artificial Intelligence.” The site revision number was updated from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T21:58:28.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-06T22:05:10.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, indicating an access restriction or server issue that prevents loading the study record.
    Difference
    18%
    Check dated 2026-09-22T22:53:52.000Z thumbnail image

Stay in the know with updates to Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page.